CBO: Bill on OTC Medicines Would Increase Deficit by $8.5 Billion

CBO: Bill on OTC Medicines Would Increase Deficit by $8.5 Billion

U.S. Congressional Budget Office

H.R. 1922, the Restoring Access to Medication Act of 2019, as ordered reported by the House Ways and Means Committee, would increase the deficit by $8.5 billion from 2020 to 2029, according to estimates released by the Congressional Budget Office on October 31.

H.R. 1922, the Restoring Access to Medication Act of 2019, as ordered reported by the House Ways and Means Committee, would increase the deficit by $8.5 billion from 2020 to 2029, according to estimates released by the Congressional Budget Office on October 31.

<a href="/lr/resolve//2b23h">H.R. 1922</a>, the Restoring Access to Medication Act of 2019, as ordered reported by the House Ways and Means Committee, would increase the deficit by $8.5 billion from 2020 to 2029, according to estimates released by the Congressional Budget Office on October 31. The bill would allow the use of health savings accounts, Archer medical savings accounts, and health flexible spending arrangements for over-the-counter medical products and menstrual products.

H.R. 1922, the Restoring Access to Medication Act of 2019, as ordered reported by the House Ways and Means Committee, would increase the deficit by $8.5 billion from 2020 to 2029, according to estimates released by the Congressional Budget Office on October 31. The bill would allow the use of health savings accounts, Archer medical savings accounts, and health flexible spending arrangements for over-the-counter medical products and menstrual products.